公司資料
Viatris Inc. 股價、新聞與催化劑
- 股票代碼:
- VTRS
- 交易所:
- NASDAQ
- 產業:
- Generics, Small Molecule Drugs
- 所在地:
- United States
股票表現
16.23 USD (0.00%)
收盤價
最後更新: 2026年8月17日
18.3B USD
市值
股價為何變動
As of Aug 17, 2026, VTRS was little changed and closed at $16.23. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Viatris is a global healthcare company formed from the combination of Mylan and Pfizer’s Upjohn business. Its portfolio spans generics, branded generics, and some specialty products, with a business model centered on scale and portfolio management.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Viatris has a global commercial footprint. It sits in generics and diversified pharmaceuticals rather than biotech.
商業模式特徵
The company generates value through product volume, geographic breadth, and lifecycle management across a broad medicines portfolio. Investors watch margin discipline, product mix, and the company’s ability to stabilize revenue after the merger integration.
生技產業定位
Viatris is outside biotech and closer to diversified pharma and generics. It matters to healthcare investors because its products are broadly used, but it is not a catalyst-heavy biotech stock.
未來催化劑
- Viatris’s near-term catalysts are biosimilar launches, portfolio simplification, and continued debt / capital-allocation progress. The next update will help show whether the company is moving from promise to a more de-risked stage of execution. Investors will care less about the label than about whether the platform can keep producing credible next steps.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。